Peptide-coated gold nanoparticles for modulation of angiogenesis in vivo

International Journal of Nanomedicine

Volumn 11, Issue , 2016, Pages 2633-2639

  Roma Rodrigues, Catarina ^a   Heuer Jungemann, Amelie ^b   Fernandes, Alexandra R ^a   Kanaras, Antonios G ^b   Baptista, Pedro V ^a  

^a UNIVERSIDADE NOVA DE LISBOA   (Portugal)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Angiogenesis activators; Antiangiogenic; CAM assay; Gold nanoparticles; Peptide coated gold nanoparticles; Vascular development

Indexed keywords

ANGIOGENIC FACTOR; GOLD NANOPARTICLE; MACROGOL; PEPTIDE COATED GOLD NANOPARTICLE; UNCLASSIFIED DRUG; GOLD; METAL NANOPARTICLE; PEPTIDE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ARTICLE; CANCER CELL; CANCER GROWTH; CELL INVASION; CHICK EMBRYO; CHORIOALLANTOIS; CONTROLLED STUDY; EMBRYO; EX VIVO STUDY; HUMIDITY; IN VITRO STUDY; IN VIVO STUDY; METASTASIS; MODULATION; NONHUMAN; REVASCULARIZATION; THERANOSTIC NANOMEDICINE; TUMOR CELL; TUMOR GROWTH; WOUND HEALING; ANIMAL; ARTERIOLE; CHEMISTRY; DRUG EFFECTS; HUMAN;

ANIMALS; ARTERIOLES; CHICK EMBRYO; CHORIOALLANTOIC MEMBRANE; GOLD; HUMANS; METAL NANOPARTICLES; NEOVASCULARIZATION, PHYSIOLOGIC; PEPTIDES;

EID: 84973464753     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S108661     Document Type: Article

References (26)

1. Zhao Y, Adjei AA. Targeting angiogenesis in cancer therapy: moving beyond vascular endothelial growth factor. Oncologist. 2015; 20: 660-673.
2. Cabral RM, Baptista PV. Anti-cancer precision theranostics: a focus on multifunctional gold nanoparticles. Expert Rev Mol Diagn. 2014; 14: 1041-1052.
3. Baptista PV. Gold nanobeacons: a potential nanotheranostics platform. Nanomedicine (London). 2014; 9: 2247-2250.
4. Ajith TA. Strategies used in clinical trials of gene therapy for cancer. J Exp Ther Oncol. 2015; 11: 33-39.
5. Sarsons CD, Tekrony A, Yaehne K, Childs S, Rinker KD, Cramb D. Testing nanoparticles for angiogenesis-related disease: charting the fastest route to the clinic. J Biomed Nanotechnol. 2014; 10: 1641-1676.
6. Skotland T, Iversen TG, Torgersen ML, Sandvig K. Cell-penetrating peptides: possibilities and challenges for drug delivery in vitro and in vivo. Molecules. 2015; 20: 13313-13323.
7. Li H, Tsui TY, Ma W. Intracellular delivery of molecular cargo using cell-penetrating peptides and the combination strategies. Int J Mol Sci. 2015; 16: 19518-19536.
8. Pang HB, Braun GB, Ruoslahti E. Neuropilin-1 and heparan sulfate proteoglycans cooperate in cellular uptake of nanoparticles functionalized by cationic cell-penetrating peptides. Sci Adv. 2015; 1: e1500821.
9. Bartczak D, Muskens OL, Sanchez-Elsner T, Kanaras AG, Millar TM. Manipulation of in vitro angiogenesis using peptide-coated gold nanoparticles. ACS Nano. 2013; 7: 5628-5636.
10. Bartczak D, Muskens OL, Nitti S, Millar TM, Kanaras AG. Nanoparticles for inhibition of in vitro tumor angiogenesis: synergistic actions of ligand function and laser irradiation. Biomater Sci. 2015; 3: 733-741.
11. Lokman NA, Elder AS, Ricciardelli C, Oehler MK. Chick chorioallantoic membrane (CAM) assay as an in vivo model to study the effect of newly identified molecules on ovarian cancer invasion and metastasis. Int J Mol Sci. 2012; 13: 9959-9970.
12. Nambiar DK, Kujur PK, Singh RP. Angiogenesis assays. Methods Mol Biol. 2016; 1379: 107-115.
13. Dohle DS, Pasa SD, Gustmann S, et al. Chick ex ovo culture and ex ovo CAM assay: how it really works. J Vis Exp. 2009; 33: 1620-1626.
14. Turkevich J, Stevenson PC, Hillier J. A study of the nucleation and growth processes in the synthesis of colloidal gold. Discuss Faraday Soc. 1951; 11: 55-75.
15. Kanaras AG, Kamounah FS, Schaumburg K, Kiely C, Brust M. Thioalkylated tetraethylene glycol: a new ligand for water soluble monolayer protected gold clusters. Chem Commun. 2002; 20: 2294-2295.
16. Bartczak D, Kanaras AG. Preparation of peptide-functionalized gold nanoparticles using one pot EDC/sulfo-NHS coupling. Langmuir. 2011; 27: 10119-10123.
17. Bartczak D, Sanchez-Elsner T, Louafi F, Millar TM, Kanaras AG. Receptor-mediated interactions between colloidal gold nanoparticles and human umbilical vein endothelial cells. Small. 2011; 7: 388-394.
18. Bartczak D, Nitti S, Millar TM, Kanaras AG. Exocytosis of peptide functionalized gold nanoparticles in endothelial cells. Nanoscale. 2012; 4: 4470-4472.
19. Ribatti D. The chick embryo chorioallantoic membrane as an in vivo assay to study antiangiogenesis. Pharmaceuticals. 2010; 3: 482-513.
20. Yadav L, Puri N, Rastogi V, Satpute P, Sharma V. Tumor angiogenesis and angiogenic inhibitors: a review. J Clin Diagn Res. 2015; 9: XE01-XE05.
21. Saraf R, Mahmood F, Amir R, Matyal R. Neuropeptide Y is an angiogenic factor in cardiovascular regeneration. Eur J Pharmacol. 2016; 776: 64-70.
22. Katoh M. Therapeutics targeting angiogenesis: genetics and epigenetics, extracellular miRNAs and signaling networks (review). Int J Mol Med. 2013; 32: 763-767.
23. Nethi SK, Mukherjee S, Veeriah V, Barui AK, Chatterjeeb S, Patra CR. Bioconjugated gold nanoparticles accelerate the growth of new blood vessels through redox signalling. Chem Commun. 2014; 50: 14367-14370.
24. Rusnati M, Presta M. Angiogenic growth factors interactome and drug discovery: the contribution of surface plasmon resonance. Cytokine Growth Factor Rev. 2015; 26: 293-310.
25. Vandekeere S, Dewerchin M, Carmeliet P. Angiogenesis revisited: an overlooked role of endothelial cell metabolism in vessel sprouting. Microcirculation. 2015; 22: 509-517.
26. Oh N, Park J-H. Endocytosis and exocytosis of nanoparticles in mammalian cells. Int J Nanomed. 2014; 9(Suppl 1): 51-63.